Peptide 22
Peptide 22 is a polypeptide that binds to EGFR. Peptide 22 competes with endogenous EGF for EGFR binding sites and is taken up by triple-negative breast cancer cells in a dose-dependent manner. Peptide 22 can be used in studies related to triple-negative breast cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3030200-17-7
- 화학식: C75H96N16O20
- 분자량:1541.66
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
제품 설명
In Vitro
Peptide 22 (YHWYGYTPENVI) (2 μM) specifically binds to EGFR on MDA-MB-468 and MDA-MB-231 triple-negative breast cancer cells, with significantly higher uptake than the parent GE11 peptide and dose-dependent binding saturation at 2 μM in MDA-MB-231 cells[1].
Peptide 22 shows high uptake in MDA-MB-468 and MDA-MB-231 triple-negative breast cancer cells but has low serum stability, requiring cyclization to enhance in vivo utility[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3030200-17-7
-
분자량 1541.66
-
화학식 C75H96N16O20
-
SMILES
O=C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CC2=CNC3=CC=CC=C23)C(N[C@@H](CC4=CC=C(C=C4)O)C(NCC(N[C@@H](CC5=CC=C(C=C5)O)C(N[C@@H]([C@H](O)C)C(N6[C@@H](CCC6)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](C(C)C)C(N[C@@H]([C@@H](C)CC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC7=CC=C(C=C7)O)N
-
Sequence
Tyr-His-Trp-Tyr-Gly-Tyr-Thr-Pro-Glu-Asn-Val-Ile
-
Sequence Shortening
YHWYGYTPENVI
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)